Visioneering Technologies, Inc. (VTI.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.08 Million AUD | -113.99% |
| 2022 | -1.9 Million USD | 76.86% |
| 2021 | -8.24 Million AUD | -2053.55% |
| 2020 | 422 Thousand AUD | -55.3% |
| 2019 | 944 Thousand AUD | 112.98% |
| 2018 | -7.27 Million AUD | 56.13% |
| 2017 | -16.58 Million AUD | -350.5% |
| 2016 | -3.68 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -1.82 Million USD | 34.95% |
| 2024 Q2 | -1.82 Million USD | 9.48% |
| 2023 Q4 | -2.8 Million USD | 37.1% |
| 2023 Q2 | -3.05 Million USD | -0.37% |
| 2023 FY | -4.08 Million AUD | -113.99% |
| 2023 Q1 | -3.03 Million USD | -59.3% |
| 2023 Q3 | -4.45 Million USD | -46.19% |
| 2022 Q2 | -5.93 Million USD | -8.39% |
| 2022 Q4 | -1.9 Million USD | 28.0% |
| 2022 FY | -1.9 Million USD | 76.86% |
| 2022 Q1 | -5.47 Million USD | 33.59% |
| 2022 Q3 | -2.65 Million USD | 55.34% |
| 2021 Q1 | -15.94 Million USD | -3009.99% |
| 2021 FY | -8.24 Million AUD | -2053.55% |
| 2021 Q4 | -8.24 Million AUD | 27.66% |
| 2021 Q3 | -11.39 Million USD | 29.44% |
| 2021 Q2 | -16.15 Million USD | -1.3% |
| 2020 Q4 | 547.91 Thousand AUD | -75.02% |
| 2020 FY | 422 Thousand AUD | -55.3% |
| 2020 Q1 | 66.67 Thousand USD | -92.94% |
| 2020 Q2 | 59.4 Thousand USD | -10.89% |
| 2020 Q3 | 2.19 Million USD | 3591.32% |
| 2019 Q4 | 944 Thousand AUD | -32.51% |
| 2019 FY | 944 Thousand AUD | 112.98% |
| 2019 Q3 | 1.39 Million USD | 196.64% |
| 2019 Q2 | -1.44 Million USD | -1.14% |
| 2019 Q1 | -1.43 Million USD | 80.33% |
| 2018 Q1 | -9.24 Million USD | 44.28% |
| 2018 Q3 | -10.06 Million USD | -4.94% |
| 2018 Q4 | -7.27 Million AUD | 27.72% |
| 2018 FY | -7.27 Million AUD | 56.13% |
| 2018 Q2 | -9.59 Million USD | -3.8% |
| 2017 Q2 | -30.43 Million USD | 0.6% |
| 2017 Q1 | -30.62 Million USD | -279.07% |
| 2017 FY | -16.58 Million AUD | -350.5% |
| 2017 Q4 | -16.58 Million AUD | 21.57% |
| 2017 Q3 | -21.14 Million USD | 30.53% |
| 2016 FY | -3.68 Million AUD | 0.0% |
| 2016 Q4 | 17.1 Million USD | 6.07% |
| 2016 Q3 | 16.12 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 83.979% |
| Adherium Limited | -6.1 Million AUD | 33.114% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -8.962% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -13.311% |
| Anteris Technologies Ltd | -28.49 Million AUD | 85.673% |
| Control Bionics Limited | -19.02 Thousand AUD | -21364.357% |
| CardieX Limited | 2.74 Million AUD | 248.67% |
| Compumedics Limited | 5.08 Million AUD | 180.262% |
| Cochlear Limited | -269.9 Million AUD | 98.487% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 684.454% |
| Cyclopharm Limited | -7.49 Million AUD | 45.554% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 73.996% |
| Nova Eye Medical Limited | -2.8 Million AUD | -45.716% |
| HeraMED Limited | -799.34 Thousand AUD | -410.785% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 128.192% |
| ImpediMed Limited | -23.48 Million AUD | 82.618% |
| InhaleRx Limited | -155.54 Thousand AUD | -2524.949% |
| LBT Innovations Limited | -604 Thousand AUD | -575.985% |
| Micro-X Limited | 826.99 Thousand AUD | 593.707% |
| Neurotech International Limited | -2.11 Million AUD | -93.461% |
| OncoSil Medical Limited | -4.43 Million AUD | 7.849% |
| PolyNovo Limited | -30.52 Million AUD | 86.625% |
| Respiri Limited | 413.68 Thousand AUD | 1086.961% |
| SomnoMed Limited | -15.16 Million AUD | 73.073% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 23.021% |
| Uscom Limited | -1.53 Million AUD | -166.749% |